SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Laboratory Corp of America Holdings – ‘8-K’ for 12/6/01

On:  Thursday, 12/6/01   ·   For:  12/6/01   ·   Accession #:  920148-1-500044   ·   File #:  1-11353

Previous ‘8-K’:  ‘8-K’ on / for 12/4/01   ·   Next:  ‘8-K’ on 12/13/01 for 12/12/01   ·   Latest:  ‘8-K’ on / for 10/27/20

Magnifying glass tilted right emoji
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size

12/06/01  Lab Corp of America Holdings      8-K:5,7    12/06/01    2:10K

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Company 8-K                                            2±    10K 
 2: EX-20       Company Press Release                                  3±    13K 

8-K   —   Company 8-K
Document Table of Contents

Page (sequential) | (alphabetic) Top
11st Page   -   Filing Submission
"Item 5. Other Events
"Item 7. Financial Statements, Pro Forma Financial Information and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 6, 2001 ------------------ (Date of earliest event reported) LABORATORY CORPORATION OF AMERICA HOLDINGS ------------------------------------------ (Exact name of registrant as specified in its charter) DELAWARE 1-11353 13-3757370 -------------- ----------- -------------- (State or other (Commission (IRS Employer jurisdiction of File Number) Identification incorporation) Number) 358 SOUTH MAIN STREET, BURLINGTON, NORTH CAROLINA 27215 ------------------------------------------------------- (Address of principal executive offices) 336-229-1127 ------------ (Registrant's telephone number, including area code) ITEM 5. OTHER EVENTS Laboratory Corporation of America -Registered Trademark- Holdings (LabCorp -Registered Trademark-)(NYSE:LH) announced that PreGen-26-Trademark- (a DNA-based colorectal cancer test) is now available through its nationwide network to physicians and their patients. The test is based on EXACT Sciences Corporation's (NASDAQ:EXAS) proprietary genomics-based technology. PreGen-26 targets Hereditary Non-Polyposis Colorectal Cancer (HNPCC) - an inherited predisposition to develop colorectal cancer. People with this syndrome have an 80 percent lifetime risk of developing the disease. ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS (c) Exhibit 20) Press release of the Company dated December 6, 2001. SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LABORATORY CORPORATION OF AMERICA HOLDINGS ------------------------------------------ (Registrant) By:/s/ BRADFORD T. SMITH ---------------------------------- Bradford T. Smith Executive Vice President, and, Secretary Date: December 6, 2001

Dates Referenced Herein

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period End:12/6/01None on these Dates
 List all Filings 
Filing Submission 0000920148-01-500044   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2020 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Oct. 31, 12:11:38.0am ET